Previously, P&G maintained its guidance range for fiscal 2025 all-in sales growth to be in the range of 2%-4% versus the prior year, stating that the combined headwinds from foreign exchange and divestitures are expected to negatively impact all-in sales growth by approximately one percentage point. The company also maintained its outlook for organic sales growth in the range of 3%-5%. During its investor day presentation, the company says it could be at the lower end of its view if China and the Middle East continue to decelerate.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PG:
- Eli Lilly appoints Jon Moeller to board of directors
- Insider Trading: Procter & Gamble’s (PG) Key Executive Sells Stock Worth $2.2M
- Procter & Gamble price target raised to $180 from $175 at Truist
- Procter & Gamble price target raised to $191 from $174 at Morgan Stanley
- Procter & Gamble price target raised to $183 from $180 at Evercore ISI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
